Imprint Medicine ApS
CVR 45469964 · Private limited company (ApS) · Active · Low risk
Imprint Medicine ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Mar 2026) shows equity of DKK -1.9m and a net result of DKK -2.0m. CEO: Peter Ahn Mouritzen, Emil Christian Fischer, Faizaan Mohammad.
Bankruptcy risk for Imprint Medicine ApS
0.6 × the average (1.41%) · higher risk than 69% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45469964
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 21k
- Auditor
- Cedra Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -77.8% |
| Current ratio | 708% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 |
|---|---|
| Gross profit | DKK -926k |
| Net profit | DKK -2.0m |
| Equity | DKK -1.9m |
| Total assets | DKK 2.5m |
| Cash | DKK 1.8m |
| Short-term debt | DKK 353k |
| Avg. employees | 3 |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Roesgaard.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 6 Mar 2025 – 31 Mar 2026 | 92 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Ahn Mouritzen | Current | |
| CEO | Emil Christian Fischer | Current | |
| CEO | Faizaan Mohammad | Current | |
| Owner (33%) | Ahn Capital ApS | Current | |
| Owner (33%) | ECF Holding ApS | Current | |
| Owner (33%) | Shams ApS | Current | |
| Owner (100%) | Peter Ahn Mouritzen | ||
| Owner (100%) | Emil Christian Fischer | ||
| Owner (100%) | Faizaan Mohammad | ||
| Auditor | Cedra Godkendt Revisionsaktieselskab | Current | |
| Founder | Ahn Capital ApS | Current | |
| Founder | ECF Holding ApS | Current | |
| Founder | Shams ApS | Current |
The CEOs' other companies
Peter Ahn Mouritzen – 1 other companies
- Ahn Capital ApS Active
Emil Christian Fischer – 1 other companies
- ECF Holding ApS Active
Faizaan Mohammad – 1 other companies
- Shams ApS Active
Address history (1 moves)
| Ole Maaløes Vej 3, 2200 København N | |
| Adolph Steens Alle 7, 2. tv, 1971 Frederiksberg C |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- AffiCon ApS Valby
- EXTITUTION ApS København Ø
- Coco Sense ApS København NV
- Everllence Denmark A/S København SV
- BioSpectre ApS København V
- Nordic Cell Therapy Group ApS København N
- FiberSure ApS København Ø
- Tasira ApS København N
- Xenogen ApS København S
- Magnalev Core ApS København SV
- Pin Joint ApS København S
- Maglya ApS København Ø
Questions and answers about Imprint Medicine ApS
Has Imprint Medicine ApS gone bankrupt?
No, Imprint Medicine ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Imprint Medicine ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of Imprint Medicine ApS?
Peter Ahn Mouritzen, Emil Christian Fischer, Faizaan Mohammad are the CEOs of Imprint Medicine ApS.
Who is the auditor of Imprint Medicine ApS?
Imprint Medicine ApS most recently used Cedra Godkendt Revisionsaktieselskab.
When was Imprint Medicine ApS founded?
Imprint Medicine ApS was founded on 6 March 2025.
What is the equity of Imprint Medicine ApS?
Equity was DKK -1.9m according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.